Global Bio-chem Technology Group Company Limited
0809.HK · HKSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | HK$2,001,095 | HK$1,373,938 | HK$12,711 | HK$746,551 |
| % Growth | 45.6% | 10,709% | -98.3% | – |
| Cost of Goods Sold | HK$1,782,413 | HK$1,330,301 | HK$337,681 | HK$698,200 |
| Gross Profit | HK$218,682 | HK$43,637 | -HK$263,374 | HK$48,351 |
| % Margin | 10.9% | 3.2% | -2,072% | 6.5% |
| R&D Expenses | HK$4,129 | HK$6,407 | HK$10,229 | HK$13,348 |
| G&A Expenses | HK$246,534 | HK$304,070 | HK$328,207 | HK$372,761 |
| SG&A Expenses | HK$354,292 | HK$370,153 | HK$267,505 | HK$399,754 |
| Sales & Mktg Exp. | HK$107,758 | HK$66,083 | HK$9,197 | HK$63,450 |
| Other Operating Expenses | HK$0 | -HK$6,407 | -HK$210,054 | HK$17,764 |
| Operating Expenses | HK$358,421 | HK$370,153 | HK$67,680 | HK$430,866 |
| Operating Income | -HK$139,739 | -HK$318,168 | -HK$269,845 | -HK$370,800 |
| % Margin | -7% | -23.2% | -2,122.9% | -49.7% |
| Other Income/Exp. Net | HK$841,548 | HK$4,019,213 | -HK$1,155,101 | -HK$38,669 |
| Pre-Tax Income | HK$745,619 | HK$3,701,045 | -HK$1,424,946 | -HK$409,469 |
| Tax Expense | -HK$23,979 | -HK$42,082 | -HK$46,788 | HK$25,920 |
| Net Income | HK$769,598 | HK$4,224,593 | -HK$1,443,068 | -HK$400,801 |
| % Margin | 38.5% | 307.5% | -11,352.9% | -53.7% |
| EPS | 0.086 | 0.47 | -0.16 | -0.045 |
| % Growth | -81.7% | 393.8% | -255.6% | – |
| EPS Diluted | 0.086 | 0.47 | -0.16 | -0.045 |
| Weighted Avg Shares Out | 8,928,680 | 8,907,406 | 8,907,406 | 8,907,406 |
| Weighted Avg Shares Out Dil | 8,928,680 | 8,907,406 | 8,907,406 | 8,907,406 |
| Supplemental Information | – | – | – | – |
| Interest Income | HK$2 | HK$3 | HK$22 | HK$271 |
| Interest Expense | HK$323,402 | HK$750,351 | HK$685,178 | HK$790,585 |
| Depreciation & Amortization | HK$283,020 | HK$241,813 | HK$270,704 | HK$402,513 |
| EBITDA | HK$16,853 | HK$4,693,209 | -HK$469,064 | HK$785,633 |
| % Margin | 0.8% | 341.6% | -3,690.2% | 105.2% |